GlobeNewswire Inc.··Trogenix Ltd.Trogenix Gene Therapy Achieves Complete Tumor Eradication in Glioblastoma Study
Trogenix publishes Nature data showing 83% complete tumor elimination in aggressive brain cancer model. Phase I/II trial dosing planned for Q2 2026.
LLYclinical trialgene therapy